e-Profile Login and ID Quick Search
Nevada News: Schedule II Issues
Reprinted form the April 2008 Nevada State Board of Pharmacy Newsletter.
Effective December 19, 2007, Drug Enforcement Administration (DEA) announced that it will once again be legal for practitioners to write up to a 90-day supply of a Schedule II medication on multiple blanks dated the same day but with “do not fill until (date)” written on the face of the prescription. Again, these prescriptions must be tendered within 14 days of the date of issue.
As of January 1, 2008, manufacturers of methadone 40 mg tablets have voluntarily agreed to restrict distribution to only those facilities authorized for detoxification and maintenance treatment of opioid addiction, and hospitals. The 40 mg methadone formulation is approved by Food and Drug Administration for addiction treatment and not approved for the treatment of pain. The 5 mg and 10 mg formulations, which are approved for the treatment of pain, will continue to be available to all authorized registrants, including retail pharmacies. Adverse events, including an alarming increase of the death rate secondary to methadone overdosage has precipitated this action.
